⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for estrogen receptor positive (er+)

Every month we try and update this database with for estrogen receptor positive (er+) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit SurgeryNCT05914792
Breast Cancer
70 Years - University of Pittsburgh
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)NCT04895358
Breast Neoplasm...
pembrolizumab
paclitaxel
nab-paclitaxel
liposomal doxor...
capecitabine
normal saline
dextrose
18 Years - Merck Sharp & Dohme LLC
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)NCT04895358
Breast Neoplasm...
pembrolizumab
paclitaxel
nab-paclitaxel
liposomal doxor...
capecitabine
normal saline
dextrose
18 Years - Merck Sharp & Dohme LLC
Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit SurgeryNCT05914792
Breast Cancer
70 Years - University of Pittsburgh
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: